A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples